Focused Ultrasound Foundation Awards (Clinical and Pre-Clinical)

Organization
Focused Ultrasound Foundation
Comments
Abstracts are accepted any time for all Program Track funding requests. Full proposals due February 1, May 1, August 1, and November 1.
Brief Description

Clinical Awards

The Foundation funds first-in-human and other innovative clinical trials involving the use of image-guided focused ultrasound to treat diseases. Funding for clinical trials is determined through a peer-review process, and the timing and dollar amounts are determined on a case-by-case basis. Priority is given to clinical indications with a clear patient need. Application instructions and materials are provided here.

This research funding mechanism is driven by a two-step application submitted online by the investigator. A one-page Research Abstract (step 1) must be submitted first. The Foundation will invite full Research Proposals (step 2) from authors of approved Research Abstracts. Once the full research proposal is received, it will be sent for external peer-review. Funding decisions (fund, revise, or reject) are returned to the applicant approximately two months after their application is submitted. In general, investigators from whom revisions are requested will have only one opportunity to address reviewer comments before a final decision (fund or reject) is made.
 

Pre-Clinical Awards

The Foundation provides funding for investigator-initiated pre-clinical or early-stage research projects through a competitive peer-reviewed application process. Applying for pre-clinical research funding is covered here.

Our Pre-Clinical Awards Program support investigator-initiated research projects in the form of one-year awards totaling approximately $100,000, paid out in three or more installments tied to progress reports throughout the term of the project. This program typically does not fund large capital purchases, overhead or institutional expenses, and the development of new focused ultrasound equipment. Exceptions to these guiding principles may be considered if the project addresses a gating factor in the near-term development of a reimbursable clinical application. Robust scientific design is prioritized over positive results (high failure risk is acceptable), and translational projects are preferred.

This research funding mechanism is driven by a two-step application submitted online by the investigator. A one-page Research Abstract (step 1) must be submitted first. The Foundation will invite full Research Proposals (step 2) from authors of approved Research Abstracts. The Research Proposals are then assigned to a program track (see below for more information) and sent for external peer-review. Funding decisions (fund, revise, or reject) are returned to the applicant approximately three months after their application is submitted. In general, investigators from whom revisions are requested will have only one opportunity to address reviewer comments before a final decision (fund or reject) is made. Please bear in mind that the review timelines depend on the program track assigned.